




























	 The	 propose	 of	 this	 article	 is	 to	 evaluate	 the	 effect	 of	 caffeine	 on	 some	 indicators	 of	 bonemetabolism	 in	 rats	 by	 biochemical	 measurement	 of	 minerals,	 bone	 densitometry	 and
histometry.	Forty	eight	Wistar	albino	male	rats,	age	6‐8	weeks	and	weighing	100±0.11	g	were
randomly	divided	 into	 four	groups	 (12	rats	each).	Each	group	of	 animals	 received	balanced
diet;	 the	 second,	 third	and	 fourth	 groups	 received	pure	 caffeine	dissolved	 in	distilled	water
with	different	oral	doses	(0.35,	0.43	and	50	mg/day)	for	12	constitutive	weeks.	Blood	samples
were	withdrawn	at	3,	6,	9	and	12	weeks.	Serum	and	urinary	calcium,	phosphorus,	magnesium
and	 caffeine	were	 estimated.	 Bone	 density	 and	 bone	 length	were	measured.	 Bone	minerals
were	also	estimated.	The	data	revealed	that	the	bone	density	was	significantly	decreased	(p	≤
0.05)	 in	 the	 fourth	 set	 (1.05±0.10	 g/cm3)	 for	 right	 femur	 rats.	 The	 length	 of	 right	 femur
increased	 with	 more	 doses	 of	 caffeine	 and	 it	 was	 highly	 significant	 in	 the	 fourth	 group
(3.40±0.12	cm).	The	proportion	of	each	calcium,	phosphors	and	magnesium	in	bone	ash	was
significantly	 lower	 (p	 ≤	 0.05).	 Serum	 levels	 of	 calcium,	 phosphors	 and	 magnesium	 were
decreased	with	increasing	the	dose	over	time.	The	 levels	of	urinary	calcium	and	magnesium
were	increased	significantly	(p	≤	0.05)	in	group	4,	but	phosphors	was	raised	(p	≤	0.05)	in	all
groups.	 In	 conclusion,	 intakes	 of	 caffeine	 in	 amounts	 >300	mg/dl	 significantly	 affected	 the
quantitative	composition	of	the	bone	and	this	finding	lead	to	be	at	a	greater	risk	for	bone	loss.
These	results	suggested	 that	appropriate	 lifestyle	 changes	 to	conserve	bone	mineral	density











Bone	 is	 a	 dynamic	 tissue	 undergoing	 a	 process	 known	 as	
bone	 remodeling	 that	 is	 a	 process	 of	 continuous	 re‐sorption	
and	 formation,	 mediated	 by	 osteoclasts	 and	 osteoblasts	 cells.	
Several	 endogenous	 and	 exogenous	 factors	 control	 the	
formation,	absorption	and	remodeling	of	bone	 tissue	[1],	such	
as	 nutrition,	 lifestyle,	 exercises,	 consumption	 of	 caffeine	 and	
genetics;	these	factors	may	be	contributed	to	the	pathogenesis	
of	osteoporosis.	Caffeine	 is	consumed	regularly	by	most	of	the	
Saud	 population.	 The	 intake	 of	 caffeine‐containing	 beverages	
has	 unwanted	 health	 consequences	 but	 it	 can	 also	 produce	
several	conceivable	health	benefits.	Caffeine,	is	associated	with	
a	 significant	 increase	 of	 periodontal	 diseases,	 induce	 loss	 of	
bone	mineral	density	(BMD)	with	5	mg	net	loss	of	calcium	per	
cup	 of	 coffee	 [2],	 increased	 risk	 of	 fractures	 and	 negative	
influence	on	calcium	retention	[3,4].	Direct	effect	of	caffeine	on	




of	 calcium	 rarely	 compensate	with	 low	 intake	 of	 calcium	 and	
the	 net	 result	 increased	 caffeine	 consumption	with	 increased	
calcium	 excretion	 in	 urine	 [6].	 In	 woman,	 increased	 calcium	
excretion	 through	 an	 hour	 of	 caffeine	 consumption	 may	 be	
more	sensitive	that	caffeine	was	effect	on	bone	metabolism,	so	
caffeine	may	represent	a	risk	factor	on	bone	in	women	[7,8].	A	
study	 conducted	 for	 women	 college	 age	 19‐28	 years	 which	
taking	 106±103	 mg/day	 caffeine	 (equivalent	 to	 one	 cup	 of	




which	 do	 not	 take	 the	 recommended	 amounts	 of	 Ca	 with	
increased	 of	 motor	 activity	 had	 a	 positive	 effect	 on	 bone	
mineral	content	[9].	




more	 than	 300	mg/dl,	 caffeine	 had	 no	 effect	 on	 bone	 density	
[10].	 Although	 there	 is	 no	 relationship	 between	 caffeine	
consumption	 and	 loss	 of	bone	density	 in	 those	 taking	 enough	
calcium	 and	 there	 is	 a	 relationship	 between	 caffeine	 and	 the	
risk	of	hip	fracture.	Therefore	it	is	recommended	that	no	more	
than	 caffeine	 consumption	 as	 300	 mg/dl	 caffeine	 [11].	 In	 a	
study	conducted	on	the	health	status	of	Saudi	women	with	age	
between	 45	 to	 60	 years	 living	 in	 Jeddah,	 it	 was	 found	 that	








Parameters Control Low	dose Medium	dose High	dose Probability 
Bone	density 1.19±0.09	**	 1.16±0.15	** 1.11±0.15 1.05±0.10 p	≤	0.05	






In	 recent	 decades,	 food	 habits	 has	 many	 changed	 in	 the	
Middle	East,	this	change	has	been	associated	with	many	social	
changes.	The	prevalent	of	fast	food	based	on	refined	foods	and	
animal	 products	 is	 non‐health	 as	 it	 is	 low	 in	 fiber,	 vegetables	
and	 fruits,	 essential	 nutrients	 such	 as	 vitamins	 and	 some	
minerals.	 Depending	 on	 these	 changes,	 unbalanced	 nutrition	
resulting	 increased	 the	 prevalent	 of	 diseases	 and	 health	
problems	 related	 to	 food	 and	nutrition	 such	 as	 diabetes,	 high	
blood	 pressure,	 cardiovascular	 disease,	 obesity,	 and	 the	
fragility	of	bone	in	Ashia	and	Arab	countries.	This	is	expected	to	
increase	with	the	population	increase	in	the	world	and	the	high	
average	 age.	 Therefore,	 osteoporosis	 become	 epidemic	 that	
threatens	 the	 health	 of	 the	 Kingdom	 of	 Saudi	 Arabia	 and	 is	
expected	 to	 increase	 the	 incidence	 of	 fractures	 due	 to	 bone	
fragility	from	1.66	million	to	the	world	in	1999	to	6.26	million	
by	the	year	2050	[13‐15].	This	study	was	evaluated	the	efficacy	








Caffeine	 in	 the	 form	 of	 pure	 C8H10N4O2	 powder	 was	
purchased	 from	Scharlau	Chemis.com	(SA).	The	oral	dose	was	
given	 in	 rats	 equivalent	 to	 as	much	 an	 adult	 weighing	 60	 kg	
[16]	They	are	three	different	 levels	as	follows:	minimum	daily	
intake	 of	 caffeine	 in	 Kingdom	 of	 Saudi	 Arabia	 (KSA)	 (258	
mg/dl);	 Average	 daily	 intake	 of	 caffeine	 in	 KSA	 (211	 mg/dl)	







The	 rats	 were	 obtained	 from	 Laboratory	 and	 Experimental	
Animal	Care	Center,	College	of	Medicine,	King	Saud	University.	
Animals	have	been	kept	 in	special	 cages,	and	maintained	on	a	
constant	 12	h	 light/12	h	dark	 cycle	with	 air	 conditioning	 and	
22	 °C	 and	 humidity	 (60%).	 Animal	 utilization	 protocols	were	





received	 balanced	 diet	 [17]	 (Table	 1)	 with	 free	 access	 to	 tap	
water	 ad	 libitum	 for	 one	 week	 before	 the	 experiment	 for	
acclimatization	 and	 during	 the	 period	 of	 the	 experiment.	 The	
second,	 third	 and	 fourth	 groups	 received	 pure	 caffeine	
dissolved	in	distilled	water	with	different	oral	doses	(0.35,	0.43	
and	 50.00	 mg/day)	 for	 12	 constitutive	 weeks	 from	 the	
beginning	of	the	experiment.		
After	 an	 overnight	 fasting,	 rats	 were	 anesthetized,	
sacrificed	and	blood	was	withdrawn	by	heart	puncture	in	tubes	
protected	 from	 light,	 then	 centrifuged	 at	 3000	 rpm	 for	 10	
minutes	 at	 4	 °C.	 Serum	 was	 immediately	 isolated,	 aliquoted,	
and	 stored	 at	 ‐80	 oC	 until	 analyzed.	 Urine	 samples	 were	
collected	in	the	last	24	hours	from	the	end	of	each	period,	then	
filtered	using	Whatman	paper	No.	42,	and	kept	at	 ‐30	 °C	until	
analyzed.	 At	 the	 end	 of	 the	 experiment,	 right	 and	 left	 femur	
bones	were	disarmed,	 cleaned	well	 and	washed	with	distilled	






Serum	 and	 urinary	 Ca,	 P	 and	 Mg	 were	 estimated	 by	
enzymatic	method	as	cited	 in	the	United	Diagnostics	 Industry.	
Serum	 and	 urinary	 caffeine	 was	 estimated	 according	 to	 the	





Bone	 density	 was	 measured	 physically	 by	 the	 way	 of	
reference	 [19],	 right	 and	 left	 femur	 bones	 were	 disarmed,	
cleaned	with	 a	 solution	 10%	 sodium	hydroxide,	 then	washed	
with	 distilled	water.	 Cut	 the	 femur	 in	 the	middle	 of	 the	 head	
grandeur	and	output	 the	bone	marrow	by	needle	and	washed	
again.	 Placed	 each	 bone	 in	 a	 tube	 filled	 with	 distilled	 water	
under	vacuum	for	90	min	to	remove	the	air	inside	the	reserved	
grandeur,	 then	 directed	 all	 the	 grandeurs	 and	 dried	 well	 on	
filter	paper,	then	weighed	and	returned	to	the	tube	containing	
distilled	 water.	 The	 weight	 were	 taken	 in	 water	 and	 density	






Bone	Length	was	measured	along	 the	 right	 femur	bone	at	






















mass	 and	 increased	 fracture	 risk	 has	 been	 associated	 with	
caffeine	 consumption	 in	 some,	 but	 not	 most,	 observational	
studies.	 The	 effects	 of	 caffeine	 on	 bone	 metabolism	 are	 still	
controversial.	 The	 present	 result	 show	 that	 caffeine	 had	
affected	 on	 bone	 density	 in	 rats.	 The	 mean	 value	 of	 bone	
density	of	 right	 femur	 in	rats	with	upper	dose	of	caffeine	was	






Parameters	 Control	 Low	dose Medium	dose High	dose Significance	
Ca%	 25.36±0.35 23.26±0.10 23.26±0.15 23.29±0.18 p	<	0.05	
P%	 0.40±0.10	 0.37±0.06 0.38±0.05 0.39±0.15 p	<	0.05	





Caffeine‐treated	 rats	 led	 to	 an	 increase	 in	 femur	 length	 in	
Group	4	for	the	last	time	period	of	the	experiment	(Table	1).	
Some	 researchers	 [21,22]	 observed	 a	 relation	 between	
caffeine	 intake	 and	 bone	 loss	 in	women.	 Conlisk	 and	 Galuska	
[22]	 conducted	 the	 effect	 of	 caffeine	 intake	 in	 doses	 of	 100	
mg/dl	on	bone	tissue	of	young	women.	BMD	was	decreased	of	
femoral	 neck	 and	 lumbar	 vertebral	 column	0.0069	 g/cm2	 and	
0.0119	g/cm2,	respectively.	There	was	an	association	between	
caffeine	 consumption	 and	 elevated	 risk	 of	 fractures	 after	
menopause	 in	women	 aged	 50‐59	who	 intake	 caffeine	with	 a	
dose	of	400	mg/dl	[23].	Higher	risk	of	fractures	was	observed	
in	 women	 aged	 40‐49	 who	 consume	more	 than	 nine	 cups	 of	
coffee/d	with	a	low	Ca	intake.	This	indicated	that	caffeine	was	a	
risk	factor	for	osteoporotic	fracture	development	[24].	
Liu	 et	 al.,	 [24]	 stated	 that	 caffeine	 may	 reduce	 BMD	 in	
growing	 rats	 through	 the	 enhancement	 in	 osteoclastogenesis	
and	 it	may	 possess	 the	 ability	 to	 enhance	 a	 cyclooxygenase‐2	
(COX‐2)/prostaglandin	 (PG)E2	 production‐regulated	 RANKL‐
mediated	osteoclastogenesis.	Caffeine	was	decreased	bones	by	
molecular	 mechanism	 of	 vitamin	 D3.	 1,25‐Dihydroxyvitamin	
D3	 (1,25(OH)2D3)	 performs	 a	 basic	 role	 in	 the	 regulation	 of	
bone	metabolism.	A	receptor	 for	 this	vitamin	(VDR,	Vitamin	D	
Receptor)	 occurs	 in	 osteoblast	 cells.	 This	 means	 that	 a	 high	
caffeine	 dose	 may	 influence	 VDR	 expression	 stimulated	 by	
1,25(OH)2D3	and	controlled	by	1,25(OH)2D3	activity	of	human	
osteoblast	cells	by	reducing	alkaline	phosphatase	activity	[5].		
The	present	 data	 concerning	 bone	 length,	 caffeine‐treated	
rats	 led	 to	an	 increase	 in	 femur	 length	 in	Group	4	 for	 the	 last	
time	 period	 of	 the	 experiment	 (Table	 1).	 The	 caffeine	
consumption	 led	 to	 increase	 in	 growth	 of	 length	 for	 bone	 in	
rats,	although	it	led	to	a	decrease	in	bone	density	[25].		
According	 to	 the	 present	 data,	 the	 percentage	 of	 Ca	 in	
femur	bone	had	a	significant	decrease	(23.26±0.10,	23.53±0.15,	
23.29±0.18	vs	25.36±0.35;	p	≤0.05)	between	groups	(Table	2).	
These	 results	 indicated	 that	 the	 reduction	 increases	 with	
increasing	 caffeine	 dose,	 which	means	 that	 caffeine's	 role	 for	
reducing	Ca	content	 in	bone.	 In	the	present	study	with	regard	
to	Mg	and	P,	there	was	a	significantly	declined	(p	<	0.05)	in	the	
percentage	 values	 of	 Mg	 and	 P	 (Mg;	 0.37±0.06,	 0.38±0.05,	
0.39±0.15	 vs	 0.40±0.10	 and	 P;	 10.67±0.05,	 10.17±0.05,	
10.44±0.16	vs	11.13±0.15,	respectively)	between	groups	(Table	
2).	Therefore,	caffeine	led	to	a	low	content	of	mineralization	of	
organic	matrix	 for	 femur	bone	 rats.	The	 impact	of	 caffeine	on	
bone	 minerals	 was	 related	 to	 Ca	 metabolism.	 Caffeine	
consumption	 was	 associated	 with	 slightly	 impairs	 Ca	
absorption	 from	 intestines;	 however	 it	 has	 no	 effect	 on	 Ca	
excretion	 in	 urine.	 Still	 its	 intake	 causes	 a	 decrease	 of	 bone	
mass	 and	 an	 increase	 of	 bone	 fracture	 risk.	 Caffeine	 has	 no	








Saudi	 Arabia	 is	 the	 Arabic	 coffee	 and	 instant	 coffee	 [15],	 the	
instant	 coffee	 was	 the	 highest	 types	 of	 caffeine,	 followed	 by	
Arabic	 coffee	3.89%	and	2.00%,	 respectively.	 This	 leads	us	 to	
consider	 consumption	 coffee	 in	 the	 quantities	 tested	 in	 the	
present	 study;	 (equivalent	 to	 258,	 and	 211	 and	 305	mg/day)	
was	a	risk	factor	for	bone	mineral	content	and	BMD	in	healthy	
Saudis	 in	 process	 of	 growth	 with	 the	 length	 of	 consumption	
time	[28].	




respectively),	 and	 that	 the	 Caffeine‐time	 (6)	 increased	 more	
significantly	in	Group	3	(2.50)	while	no	increase	in	Group	2	and	
4.	 The	 caffeine‐time	 (9)	 had	 increased	 more	 significantly	 in	
Group	2	(1.49)	while	no	increase	in	Group	3	and	4	(Figure	1).	In	
the	present	study	regards	to	urine,	the	level	of	caffeine	showed	
an	 effect	 of	 interaction	 between	 caffeine‐treated	 rats	 and	
increasing	 time	 (p	 ≤	 0.01)	 (Figure	 2).	 It	 was	 found	 that	 the	
Caffeine‐time	 (3)	 increased	more	 significantly	 in	 the	 Group	 2	
(199.00),	 as	 well	 as	 in	 time	 (6	 and	 9;	 303.22	 and	 450.98;	
respectively).	
	
Figure	 1.	 Serum	 caffeine	 level	 at	 3,	 6	 and	 9	 weeks	 of	 control	 and	 animal	







Figure	2.	Urinary	 caffeine	 at	 3,	 6	 and	 9	weeks	 in	 the	 controls	 and	 animal	






the	 experiment	 in	 serum,	 the	 level	 of	 Ca,	 P	 and	 Mg	 were	









1	 2 3 4	
Ca	(mg/dl)	 	 	 	 	 	
0	 9.8±	1.11 9.8±1.11 9.8±1.01 9.8±0.97	
3	 9.0±	1.43	 6.8±1.43	 6.3±0.73	 8.7±2.03	
6	 8.2±1.71	 8.2±1.71	 7.6±1.43	 9.1±1.01	
9	 10.1±2.22	 8.3±2.22	 7.9±1.91	 9.8±1.32	
Mg	(mg/dl)	 	 	 	
0	 0.94±0.29	 0.96±0.29	 0.96±0.12	 0.92±0.33	
3	 0.82±0.16 0.71±0.59 0.67±0.36 0.84±0.06	
6	 0.85±0.11	 0.83±0.18	 0.85±0.17	 0.85±0.59	
9	 0.94±0.09	 0.85±0.13	 0.82±0.03	 0.95±0.06	
P	(mg/dl)	 	 	 	
0	 3.83±0.29	 4.24±0.29	 3.47±0.12	 2.83±0.33	
3	 2.74±0.16	 2.19±0.59	 2.21±0.36	 2.65	±0.06	
6	 2.54±0.06 2.55±0.11 2.83±0.46 2.08±0.58	





Parameters	 Times	 Control	 Low	dose Medium	dose High	dose Significance
Ca	(mmol/L)	 	 	 	 	 	 	
3	 0.62±0.56	a	 1.12±0.22	a	 1.32±0.72	a		 0.28±0.13	a	 p	≤	0.05	
6	 0.17±0.06	a	 0.37±0.46	a	 0.30±0.37	a	 0.25±0.18	a	 p	≤	0.05	
9	 0.16±0.05	a	 0.34±0.05	a 01.4±0.04	a 0.36±0.45	a	 p	≤	0.05	
Final	 0.17±0.06	a	 0.31±0.15	a 0.11±0.03	a 0.40±0.32	d	 p	≤	0.05	
P	(mmol/L)	 	 	 	
3	 1.25±1.14	a	 0.76±0.07	a	 0.37±0.19	c	 0.43±0.08	d	 p	≤	0.05	
6	 0.41±0.28	a	 0.86±0.62	b	 0.27±0.05	a	 0.29±0.19	a	 p	≤	0.05	
9	 0.43±0.32	a	 0.18±0.08	a	 0.31±0.18	a	 3.01±0.63	a	 p	≤	0.05	
Final	 0.45±0.35	a	 0.21±0.06	a 0.25±0.14	a 1.54±0.30	d	 p	≤	0.05	
Mg	(mmol/L)	 	 	 	 	 	 	
3	 2	71±0.18	a	 3.54±2.13	a 5.65±1.21	c 4.19±2.22	d	 p	≤	0.05	
6	 4.34±1.00	a	 4.04±1.67	a	 5.01±1.29	a	 4.94±1.49	a	 p	≤	0.05	
9	 4.25±1.09	a	 6.01±0.72	a	 5.02±1.52	a	 6.70±1.54	d	 p	≤	0.05	












Group	 3	 (p	 <0.05)	 compared	 to	 the	 control	 group	 (Table	 4).	
There	was	no	significant	difference	in	the	values	of	Ca	between	
three	caffeine‐treated	groups	compared	to	control	group.	When	
comparing	 the	 level	 of	 Ca	 and	 P	 in	 urine	 during	 the	 second	
period	 with	 the	 control	 group,	 it	 noticed	 that	 no	 significant	




of	 (P)	was	 increased	 significantly	 (p	 ≤	 0.05)	 in	 Group	 4.	 The	
urinary	 metals	 at	 the	 end	 of	 the	 experiment	 was	 clear	
compared	 to	 the	 control	 group,	 the	 level	 of	 Ca	 and	Mg	were	
increased	significantly	(p	≤	0.05)	 in	Group	4,	but	p	was	raised	
(p	≤	0.05)	in	all	groups.	
Some	 authors	 observed	 a	 relationship	 between	 caffeine	




time	 periods	 of	 two	 groups	 (low	 and	 high‐caffeine	 dose),	
caffeine	did	not	effect	on	Ca	excretion	when	comparing	groups	
with	the	three	time	periods,	whereas	output	of	P	did	not	affect	
by	 caffeine	 during	 the	 first	 and	 second	 periods	 but	 increased	
significantly	 (p	 ≤	0.05)	during	 the	 third	period.	Other	 authors	
were	 contrary,	 they	 stated	 that	 caffeine	 led	 to	 a	 defect	 in	 Ca	






Intakes	 of	 caffeine	 in	 amounts	 >300	 mg/dl	 significantly	
affected	the	quantitative	composition	of	the	bone	and	lead	to	a	
greater	 risk	 for	 bone	 loss.	 These	 results	 suggested	 that	
appropriate	lifestyle	changes	to	conserve	BMD	by	reducing	the	
consumption	of	 caffeine	 and	need	 further	 studies	 to	 elucidate	
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